FilingReader Intelligence

Leadman Biochemistry stock jumps 45% on acquisition plans

August 2, 2025 at 05:32 AM UTCBy FilingReader AI

Beijing Leadman Biochemistry's stock price jumped 45.06% over two trading days following announcement of plans to acquire up to 70% of Beijing Xiansheng Xiangrui Biological Products through a cash transaction.

The acquisition constitutes a major asset restructuring currently in preliminary planning stages.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

SZSE:300289Shenzhen Stock Exchange
Pharmaceuticals

News Alerts

Get instant email alerts when Beijing Leadman Biochemistry publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →